AceAge closes Series A financing round

Ontario Industry Updates
Written By Maura Campbell
AceAge-Logo-Wordmark-Tagline.png

AceAge, a healthcare technology company with its innovative medication dispenser, Karie, announced that it has closed a CA $5 million Series A financing round led by Longliv Ventures, with the participation of a fund managed by the Bloom Burton Investment Group. Karie allows users with complex medication regimes to take their medication independently. 

Maura Campbell
Previous

Ripple Therapeutics secures Licensing Agreement and Series A Financing led by Théa Open Innovation
Next

Molly Shoichet named one of the Top 100 Most Powerful Women in Canada